[et_pb_section fb_built=\u00bb1″ admin_label=\u00bbsection\u00bb _builder_version=\u00bb3.22″ global_colors_info=\u00bb{}\u00bb][et_pb_row admin_label=\u00bbrow\u00bb _builder_version=\u00bb3.25″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb3.25″ custom_padding=\u00bb|||\u00bb global_colors_info=\u00bb{}\u00bb custom_padding__hover=\u00bb|||\u00bb][et_pb_text admin_label=\u00bbText\u00bb _builder_version=\u00bb4.10.6″ background_size=\u00bbinitial\u00bb background_position=\u00bbtop_left\u00bb background_repeat=\u00bbrepeat\u00bb hover_enabled=\u00bb0″ global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0″]<\/p>\n

Chemrar\/ 27 Novem\u00adber 2013\/ \u2014 Russ\u00adian bil\u00adlion\u00adaire Roman Abramovich<\/strong> will invest<\/strong> up to $1 bil\u00adlion in Skolkovo-Park,<\/strong> an exec\u00adu\u00adtive from his invest\u00adment vehi\u00adcle Mill\u00adhouse said Tues\u00adday. Mill\u00adhouse has already invested $400 mil\u00adlion in build\u00adings located in Skolkovo-Park and is plan\u00adning to spend up to $1 bil\u00adlion in total, the company\u2019s devel\u00adop\u00adment head Igor Pyat\u00adi\u00adbra\u00adtov said Tues\u00adday. Skolkovo-Park is real estate and park devel\u00adop\u00adment located on the edge of Moscow.<\/p>\n

It is expected to be com\u00adpleted by 2018 and includes a makeover of Meshch\u00ader\u00adsky Park, new trans\u00adport facil\u00adi\u00adties, res\u00adi\u00adden\u00adtial build\u00adings and a large golf course, accord\u00ading to Mill\u00adhouse.<\/p>\n

Source: http:\/\/www.chemrar.ru\/eng\/i-news\/index.php?ELEMENT_ID=17247<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

Chemrar\/ 27 Novem\u00adber 2013\/ \u2014 Russ\u00adian bil\u00adlion\u00adaire Roman Abramovich will invest up to $1 bil\u00adlion in Skolkovo-Park, an exec\u00adu\u00adtive from his invest\u00adment vehi\u00adcle Mill\u00adhouse said Tues\u00adday. Mill\u00adhouse has already invested $400 mil\u00adlion in build\u00adings located in Skolkovo-Park and is plan\u00adning to spend up to $1 bil\u00adlion in total, the company\u2019s devel\u00adop\u00adment head Igor Pyat\u00adi\u00adbra\u00adtov said […]<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":8789,"menu_order":5,"comment_status":"open","ping_status":"open","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"Chemrar\/ 27 Novem\u00adber 2013\/ \u2014 Russ\u00adian bil\u00adlion\u00adaire Roman Abramovich<\/strong> will invest<\/strong> up to $1 bil\u00adlion in Skolkovo-Park,<\/strong> an exec\u00adu\u00adtive from his invest\u00adment vehi\u00adcle Mill\u00adhouse said Tues\u00adday. Mill\u00adhouse has already invested $400 mil\u00adlion in build\u00adings located in Skolkovo-Park and is plan\u00adning to spend up to $1 bil\u00adlion in total, the company\u2019s devel\u00adop\u00adment head Igor Pyat\u00adi\u00adbra\u00adtov said Tues\u00adday. Skolkovo-Park is real estate and park devel\u00adop\u00adment located on the edge of Moscow.\n\nIt is expected to be com\u00adpleted by 2018 and includes a makeover of Meshch\u00ader\u00adsky Park, new trans\u00adport facil\u00adi\u00adties, res\u00adi\u00adden\u00adtial build\u00adings and a large golf course, accord\u00ading to Mill\u00adhouse.\n\nSource: http:\/\/www.chemrar.ru\/eng\/i-news\/index.php?ELEMENT_ID=17247<\/a>\n\n","_et_gb_content_width":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-8829","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8829","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/comments?post=8829"}],"version-history":[{"count":4,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8829\/revisions"}],"predecessor-version":[{"id":10287,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8829\/revisions\/10287"}],"up":[{"embeddable":true,"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/pages\/8789"}],"wp:attachment":[{"href":"https:\/\/www.chameleon-pharma.com\/es\/wp-json\/wp\/v2\/media?parent=8829"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}